Adjuvant camrelizumab significantly improves event-free survival in patients with locoregionally advanced nasopharyngeal ...

Chinese scientists have developed a new treatment for nasopharyngeal carcinoma that helps patients live longer and have a ...

However, some patients relapse or present with de novo metastatic disease. For those not recently exposed to platinum-based therapies, the standard of care includes gemcitabine, cisplatin, and the ...

Nasopharyngeal Cancer Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

THE interest of those concerned in any way with the provision of protection against inhalation hazards, especially those associated with work with radioactive materials, has been stimulated by the ...

Phase III DIPPER trial shows that adjuvant camrelizumab administered after induction-concurrent chemoradiotherapy ...

Chinese University of Hong Kong researchers find patients with cancer-associated EBV DNA in blood have 87-fold increased risk ...

Chinese University of Hong Kong researchers find patients with cancer-associated EBV DNA in blood have 87-fold increased risk ...

Considering taking supplements to treat nasopharyngeal cancer? Below is a list of common natural remedies used to treat or reduce the symptoms of nasopharyngeal cancer. Follow the links to read ...

Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National Medical Products Administration (NMPA) for ...

(AKESF) said in a statement that its Penpulimab has been approved for the first-line treatment of recurrent or metastatic nasopharyngeal cancer or NPC, alongside chemotherapy. The approval has ...